Arjo becomes exclusive distributor for BBI’s innovative pressure ulcer assessment device

Bruin Biometrics (BBI), has agreed for Arjo, supplier of medical devices, to become the exclusive distributor for BBI’s pressure ulcer assessment device, the SEM Scanner.

BBI is a US-based technology company committed to modernising health care with biometric sensor technology for the early detection and monitoring of chronic, preventable conditions in collaboration with clinicians.

According to NHSI, in the UK, between 1700-2000 patients develop a pressure ulcer per month and that treating pressure ulcers costs the NHS more than £3.8m per month.

Discussing the new distribution agreement, Joacim Lindoff, President & CEO of Arjo, said: “The BBI technology is well aligned with our strategy and will help us strengthen our offering of outcome-based solutions. By combining our extensive knowledge and sales network with BBI’s technology, we will help drive a shift in pressure injury management towards prevention and ultimately better clinical and financial outcomes.

“This investment means we will gain further access to the wound care market, where we see substantial growth potential.”

The new Distribution Agreement commenced as signed on October 8 2020.

Martin Burns, CEO of BBI, added: “Few medical conditions ever present themselves to an attainable and near-term preventative solution as pressure injuries. Realising the outcome of preventing preventable pressure injuries benefits millions of patients affected and tens of thousands who die from related complications every year. Economic savings through prevention extend to many tens of billions of dollars annually.

“Pressure injury incidence can and should be reduced. Arjo’s knowledge, expertise and scale will enable many patients and their families, providers, and payors to benefit from this solution worldwide.”

BBI’s Provizio® SEM Scanner is the first hand-held wireless scanner with intelligence inside for fast and easy pressure ulcer risk assessments and the only SEM Scanner that acts as an adjunct to routine clinical skin assessment on the sacrum and heels.

In clinical practice since 2014, the new Provizio SEM Scanner has, in preliminary laboratory testing, shown the same precision as the previous BBI SEM Scanner 200 model. The results are published in the International Wound Journal.

“Arjo represent an ideal partner for BBI; they understand prevention and are vigorously helping their clinical customers achieve the clinical outcome of full prevention and cost savings from prevention,” continued Martin. “Their platform extends from acute to post-acute care, globally, and we are delighted to be extending our working relationship with them.”